Eurofins Scientific Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Eurofins Scientific Stock Forecast and Price Target
If the average price target of 59.00€ set by five distinguished experts for Eurofins Scientific over the past few weeks is reached this year, there would be a potential upside of approximately 2.61% from the last closing price in April, 2024. This potential increase is based on a high estimate of 83.00€ and a low estimate of 48.00€. If you want to buy ERF stock, it might be a good idea to look at its competitors too.
2.61% Upside
Eurofins Scientific Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Eurofins Scientific's Price has gone down from 75.02€ to 0.00€ – a 100.00% drop. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach 64.00€ – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Eurofins Scientific will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$571.73 | Buy/Sell | $591.94 | 7.57% |
| SHL Stock Forecast | Siemens Healthineers | Buy |
8
|
52.30€ | Buy/Sell | 56.34€ | 14.72% |
| IQV Stock Forecast | IQVIA Holdings | Outperform |
15
|
$233.98 | Buy/Sell | $267.27 | 17.53% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF513.80 | Buy/Sell | CHF516.89 | 13.86% |
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$136.37 | Buy/Sell | $138.82 | 11.09% |
Eurofins Scientific Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Eurofins Scientific has grown by 19.78%, going from 5.44€B to 6.51€B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach 7.02€B – an increase of 7.73%. Over the next seven years, experts anticipate that Revenue growth for Eurofins Scientific will be 34.45%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ICLR Stock Forecast | ICON Public | Buy |
16
|
$300.08 | Buy/Sell | $306.07 | 19.97% |
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$198.35 | Buy/Sell | $241.28 | 21.50% |
| SGSN Stock Forecast | SGS | Hold |
18
|
CHF82.10 | Buy/Sell | CHF86.34 | 9.62% |
.jpg)
Eurofins Scientific Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Eurofins Scientific's Dividend per Share has fallen from 0.68€ to 0.50€ – a 26.47% decrease. In the next year, analysts predict that Dividend per Share will reach 1.01€ – an increase of 102.00%. For the next seven years, the forecast is for Dividend per Share to grow by 221.45%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 603259 Stock Forecast | WuXi AppTec | Buy |
18
|
¥41.60 | Buy/Sell | ¥121.48 | 61.71% |
| DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$135.42 | Buy/Sell | $141.17 | 7.07% |
| BVI Stock Forecast | Bureau Veritas | Outperform |
18
|
27.32€ | Buy/Sell | 26.96€ | 13.47% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
99.50€ | Buy/Sell | 105.55€ | 14.32% |
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$102.09 | Buy/Sell | $121.84 | 22.32% |
| SW Stock Forecast | Sodexo | Outperform |
16
|
79.00€ | Buy/Sell | 114.78€ | 13.92% |
Eurofins Scientific EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Eurofins Scientific's EBITDA has decreased by 6.82%, going from 1.27€B to 1.19€B. For next year, the 12 analysts predict EBITDA of 1.46€B, which would mean an increase of 23.17%. Over the next seven years, the pros' prediction is EBITDAof 1.93€B, which would mean a seven-year growth forecast of 62.54%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CRL Stock Forecast | Charles River Laboratories Int... | Outperform |
16
|
$227.81 | Buy/Sell | $229.97 | 21.48% |
| EXAS Stock Forecast | Exact Sciences | Buy |
8
|
$58.79 | Buy/Sell | $90.32 | 50.72% |
| NTRA Stock Forecast | Natera | Outperform |
7
|
$91.28 | Buy/Sell | $74.41 | 12.84% |
Eurofins Scientific EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Eurofins Scientific's EBIT has decreased from 904.40€M to 717.00€M – a 20.72% drop. In the next year, analysts expect EBIT to reach 932.73€M – an increase of 30.09%. For the next seven years, the forecast is for EBIT to grow by 85.67%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.80 | Buy/Sell | $49.29 | 13.80% |
| ITRK Stock Forecast | Intertek Group | Outperform |
18
|
£49.48 | Buy/Sell | £44.87 | 6.71% |
| SHL Stock Forecast | Sonic Healthcare | Hold |
18
|
$26.74 | Buy/Sell | $34.12 | 15.93% |
Eurofins Scientific EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Eurofins Scientific's EPS has gone down from 3.61€ to 0.00€ – a 100.00% drop. In the coming year, analysts are expecting an increase in EPS, predicting it will reach 3.08€ – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Eurofins Scientific will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$275.60 | Buy/Sell | $536.80 | 58.45% |
| ADEN Stock Forecast | Adecco Group | Hold |
18
|
CHF31.12 | Buy/Sell | CHF42.09 | 29.43% |
| ALQ Stock Forecast | ALS | Outperform |
18
|
$13.37 | Buy/Sell | $12.63 | -0.15% |
.jpg)